Bluefin Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-4,908
| Closed | -$435K | – | 328 |
|
|
2016
Q4 | $435K | Buy |
4,908
+87
| +2% | +$7.71K | 0.03% | 199 |
|
|
2016
Q3 | $465K | Buy |
4,821
+660
| +16% | +$63.7K | 0.02% | 146 |
|
|
2016
Q2 | $357K | Buy |
+4,161
| New | +$357K | 0.04% | 186 |
|
|
2016
Q1 | – | Sell |
-7,110
| Closed | -$802K | – | 347 |
|
|
2015
Q4 | $802K | Buy |
7,110
+1,992
| +39% | +$225K | 0.06% | 197 |
|
|
2015
Q3 | $517K | Buy |
5,118
+657
| +15% | +$66.4K | 0.03% | 221 |
|
|
2015
Q2 | $549K | Buy |
4,461
+2,661
| +148% | +$327K | 0.03% | 224 |
|
|
2015
Q1 | $206K | Sell |
1,800
-6,900
| -79% | -$790K | 0.02% | 276 |
|
|
2014
Q4 | $879K | Buy |
8,700
+3,222
| +59% | +$326K | 0.05% | 214 |
|
|
2014
Q3 | $500K | Buy |
5,478
+2,700
| +97% | +$246K | 0.03% | 299 |
|
|
2014
Q2 | $200K | Buy |
+2,778
| New | +$200K | 0.01% | 427 |
|
|
2013
Q3 | – | Sell |
-15,954
| Closed | -$900K | – | 386 |
|
|
2013
Q2 | $900K | Buy |
+15,954
| New | +$900K | 0.08% | 190 |
|